<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Assessing and managing nonadherence with continuous positive airway pressure (CPAP) for adults with obstructive sleep apnea</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Assessing and managing nonadherence with continuous positive airway pressure (CPAP) for adults with obstructive sleep apnea</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Assessing and managing nonadherence with continuous positive airway pressure (CPAP) for adults with obstructive sleep apnea</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Terri E Weaver, PhD, RN, FAAN, ATSF</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy Collop, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 15, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Obstructive sleep apnea (OSA) is a disorder that is characterized by obstructive apneas and hypopneas due to repetitive collapse of the upper airway during sleep. Continuous positive airway pressure (CPAP) is an effective therapy for OSA, but adherence is frequently suboptimal [<a href="#rid1">1</a>]. The prevalence, consequences, and risk factors for nonadherence, as well as interventions to improve adherence are reviewed in this topic. Initiation of CPAP therapy is described separately. (See  <a class="medical medical_review" href="/z/d/html/7677.html" rel="external">"Titration of positive airway pressure therapy for adults with obstructive sleep apnea"</a>.) </p><p class="headingAnchor" id="H3239034768"><span class="h1">NONADHERENCE</span></p><p class="headingAnchor" id="H396327361"><span class="h2">Definition (hours of CPAP use)</span><span class="headingEndMark"> — </span>In patients with OSA, it is generally accepted that nonadherence be defined as using CPAP for less than an average of four hours per night or less than 70 percent of nights (ie, less than five nights per week).<strong> </strong>We set expectations with our patients that CPAP should be used for a <strong>minimum</strong> of four hours per night for five to seven nights a week. However, we encourage a level of adherence greater than the set minimum on an individual basis to determine the appropriate target for nightly usage. </p><p class="bulletIndent1"><span class="glyph">●</span>The four-hour cutoff is typically used since several studies have shown that four or more hours of CPAP use is associated with normalization of daytime sleepiness as well as improvement in quality of life, neurocognitive function, cardiovascular disease, and diabetes [<a href="#rid1">1-7</a>]. Consequently, insurers and The Centers for Medicare and Medicaid Services (CMS) use four hours per night for 70 percent of nights as the cutoff point differentiating adherence and nonadherence. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>However, targeting longer use is appropriate and is dependent upon individual patient goals. For example, if the goal is to improve self-reported sleepiness, it has been shown that four hours of use is sufficient to achieve a normal score on the Epworth Sleepiness Scale [<a href="#rid2">2</a>]. When evaluating fitness for duty in a commercial truck driver, one study showed that six hours was needed to achieve a normal level of objective alertness in the multiple sleep latency test, and 7.5 hours was required to improve to normal daytime functioning on the Functional Outcomes of Sleep Questionnaire [<a href="#rid2">2</a>]. Another study showed that five hours of use improved neurobehavioral performance [<a href="#rid3">3</a>]. Several other studies indicate that greater than six hours per night results in normal levels of objectively measured and self-reported daytime sleepiness, as well as significantly improved memory and daily functioning [<a href="#rid2">2,3,8</a>].</p><p></p><p class="headingAnchor" id="H3"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>It has been estimated that almost half of patients are nonadherent, when nonadherence is defined as a mean of less than four hours of use per night, but the range is broad (29 to 83 percent) [<a href="#rid1">1,9</a>]. The prevalence when the definition also includes less than 70 percent of nights is unknown.</p><p>Overall, the average duration of CPAP use is approximately five to six hours per night across numerous studies [<a href="#rid10">10</a>]. Among those who are nonadherent, the mean duration of use was found in one study to be three hours per night (on those nights when it is used) compared with those who were adherent, in whom the mean duration of CPAP use was typically six hours per night [<a href="#rid1">1</a>]. </p><p class="headingAnchor" id="H4"><span class="h2">Sequalae</span><span class="headingEndMark"> — </span>In patients with OSA who are adherent, there are several benefits associated with CPAP use including improved daytime sleepiness, systemic blood pressure, quality of life, neurobehavioral performance, and a reduced risk of motor vehicle accidents. These effects are typically felt within days to weeks of starting CPAP therapy. Randomized trials have not shown an impact on mortality. One retrospective study showed a dose-response relationship between improved adherence and reduced cardiovascular events [<a href="#rid11">11</a>]. The benefits of CPAP are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Efficacy'</a>.)</p><p>Similarly, the impact of nonadherence is typically felt within days to weeks of stopping CPAP therapy [<a href="#rid12">12-15</a>]. This was illustrated by a trial that included 41 patients with OSA who had been using CPAP successfully for at least one year without subjective daytime sleepiness [<a href="#rid15">15</a>]. Subtherapeutic CPAP (“CPAP withdrawal”) led to recurrence of abnormal respiratory events within one night (mean apnea-hypopnea index [AHI] &gt;25 events per hour). Increased morning and evening blood pressure, morning heart rate, and subjective daytime sleepiness were seen within two weeks of withdrawal. Psychomotor performance remained unaffected. (See  <a class="medical medical_review" href="/z/d/html/7688.html" rel="external">"Quantifying sleepiness", section on 'Epworth Sleepiness Scale (ESS)'</a>.)</p><p class="headingAnchor" id="H3911864816"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Risk factors for nonadherence have been identified by observational studies and are listed in the table  (<a class="graphic graphic_table graphicRef50144" href="/z/d/graphic/50144.html" rel="external">table 1</a>). Importantly, nonadherence is usually multifactorial [<a href="#rid9">9,16-20</a>]. An adherence index based upon polysomnographic indices has been described but is not validated or routine [<a href="#rid21">21</a>]. </p><p>Nonadherence is often identified during the first two weeks of CPAP use and predicts long-term nonadherence [<a href="#rid20">20,22</a>]. Consistent among studies is that major predictors of nonadherence during the <strong>first two weeks</strong> include the following [<a href="#rid18">18,19,23</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Higher residual AHI (ie, poor efficacy of CPAP delivery)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Poor self-efficacy (defined as one's motivation, volition, and confidence to engage in a healthy behavior)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Younger age (weak association)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Being African-American (perhaps intertwined with lower socioeconomic status)</p><p></p><p>The following factors have been associated with <strong>long-term</strong> nonadherence with CPAP therapy:</p><p class="bulletIndent1"><span class="glyph">●</span>CPAP use &lt;4 hours/night during the first two weeks of therapy [<a href="#rid1">1,24</a>]   </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Problems encountered during the first night of use [<a href="#rid25">25</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moderate to severe OSA (ie, an AHI &gt;15 events per hour of sleep; weak relationship) [<a href="#rid4">4,9,10,16,26</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Certain psychological traits:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lack of a positive perspective regarding the benefit of CPAP therapy [<a href="#rid27">27,28</a>] and poor self-efficacy [<a href="#rid1">1,26-29</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Claustrophobic tendencies [<a href="#rid30">30</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lack of ability to overcome obstacles and problem-solve [<a href="#rid31">31</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Unsupportive bed partner [<a href="#rid26">26</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CPAP affecting sleep of bed partner [<a href="#rid18">18</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Less severe oxyhemoglobin desaturation during sleep on diagnostic polysomnography [<a href="#rid32">32</a>] </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Poor sleep-efficiency during CPAP titration (ie, time asleep/time in bed) [<a href="#rid33">33</a>] </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Small nasal volume, nasal polyposis, and high nasal resistance [<a href="#rid34">34-37</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Comorbid insomnia [<a href="#rid38">38</a>] </p><p></p><p>It is uncertain whether the routine application of heated humidification predicts adherence, since the evidence is conflicting. While some studies indicate that heated humidification enhances adherence [<a href="#rid39">39-43</a>], other studies do not [<a href="#rid41">41,42,44-46</a>]. It has been suggested that humidification affects adherence only in those who experience nasal congestion [<a href="#rid40">40,44</a>]. However, the issue may be moot since most CPAP machines come equipped with a heated humidifier and guidelines encourage routine use of this function [<a href="#rid47">47</a>]. </p><p>The impact of different methods of CPAP delivery on adherence has been studied. Although auto-titrating CPAP or pressure relief CPAP are often prescribed in patients when nonadherence is due to intolerance of positive pressure, most studies have found that routinely prescribing these measures is not associated with increased adherence rates when compared to conventional CPAP [<a href="#rid9">9,48,49</a>]. In-person set up has also been shown to improve adherence [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H2948799956"><span class="h1">EVALUATION FOR NONADHERENCE</span></p><p class="headingAnchor" id="H3430526466"><span class="h2">Frequent provider follow-up during first two weeks</span><span class="headingEndMark"> — </span>In patients with OSA, we evaluate and manage nonadherence in the <strong>first two weeks</strong> of CPAP therapy, preferably within the first few days [<a href="#rid47">47</a>]. We also re-evaluate at every follow up visit thereafter. Assessment can be done during in-person visits, or by telephone or telehealth encounters [<a href="#rid51">51,52</a>]. This is in keeping with the American Academy of Sleep Medicine who recommends follow-up within the first two weeks to optimize adherence, then monthly and yearly, depending on level of adherence and resolution of symptoms [<a href="#rid47">47</a>]. The evaluation should focus on the following: </p><p class="bulletIndent1"><span class="glyph">●</span>Determining whether or not the patient is tolerating CPAP therapy, the level of adherence, and perceived benefits (see <a class="local">'Clinical assessment'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Identifying and troubleshooting any side effects (see <a class="local">'Side effect management'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Offering general encouragement and reinforcement of the importance of nightly CPAP use (see <a class="local">'Behavioral therapy'</a> below)</p><p></p><p>Early assessment of adherence is based upon data suggesting that patients generally make the decision to adhere to CPAP early during the first week of therapy, usually by the second to fourth day [<a href="#rid1">1,24,53,54</a>]. Those who adhere generally increase their duration of nightly use gradually. As an example, one study demonstrated that patients who used CPAP for more than two years increased their duration of use approximately eight minutes per night during each year of therapy [<a href="#rid55">55</a>].</p><p>We adopt a multidisciplinary approach to evaluating and managing nonadherence. Effective teams consist of personnel experienced in sleep medicine including a physician, technologist, advanced practice nurse, and psychologist as well as the bed partner [<a href="#rid56">56,57</a>]. However, the level of support may vary depending on the patients and the institution. For example, patients who have no or minimal issues with adherence and who tolerate CPAP easily need less support than those who struggle during the first few nights with CPAP. In addition, institutions vary in their ability to provide expertise on a frequent basis. </p><p class="headingAnchor" id="H1640460553"><span class="h2">Clinical assessment</span><span class="headingEndMark"> — </span>We typically evaluate CPAP use using clinical and objective criteria [<a href="#rid47">47,58</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Clinical - We interview patients <strong>and their bed partner</strong> who are asked directly about their estimated hours of nightly use, frequency of weekly use, and reasons for nonadherence, if present. We assess for side effects including a sense of claustrophobia, ulceration, nasal or upper airway dryness or congestion, intolerance of the sensation of pressure or noise, frequent awakenings, mask discomfort and leak, and aerophagia or nausea. We also question patients about their perception of CPAP efficacy (eg, quality of sleep with CPAP, daytime sleepiness, general daytime performance, snoring and choking episodes during sleep, mood, motor vehicle accidents), the impact of CPAP on their bed partner (eg, their quality of sleep and intimacy), and any psychosocial issues that may be impeding therapy. We typically also assess the level of sleepiness on CPAP using either a self-report measure such as the Epworth Sleepiness Scale or an objective measure (eg, Psychomotor Vigilance Task).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Objective – As an objective measure of adherence, we assess downloaded data from the patient’s CPAP device. Most newer devices contain data on hours of “mask-on” use per day, patterns of use (eg, how many nights per week CPAP was used for a certain duration), mask leaks, and efficacy as measured by the device-measured apnea hypopnea index (AHI<sub>flow</sub>). (See  <a class="medical medical_review" href="/z/d/html/97878.html" rel="external">"Downloading data from positive airway pressure devices in adults"</a>.)</p><p></p><p class="headingAnchor" id="H2575541341"><span class="h2">Electronic resources (telehealth, telemonitoring, active patient engagement)</span><span class="headingEndMark"> — </span>Newer electronic resources may offer some benefit in the evaluation and management of adherence. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>Telehealth – Telehealth (eg, virtual visits, web-based educational tools, applications) is increasingly utilized to connect with CPAP users to address symptoms, troubleshoot equipment problems, and provide motivational interviewing-based interventions to enhance adherence [<a href="#rid59">59-63</a>] (see <a class="local">'Motivational enhancement'</a> below). As an example, in a meta-analysis of seven trials, only two of which were small randomized trials, use of patient-facing applications (PFAs) was associated with improved CPAP adherence for significantly more hours per night (range 0.7 to 1.3 hours more) and for a greater proportion of nights [<a href="#rid63">63</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Telemonitoring – Telemonitoring involves feedback that is given to the patient based upon data downloaded from the CPAP device. However, studies have yielded conflicting results on the value of telemonitoring alone as a tool to improve patient adherence [<a href="#rid60">60,64,65</a>]. (See  <a class="medical medical_review" href="/z/d/html/97878.html" rel="external">"Downloading data from positive airway pressure devices in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Combined resources - Combining electronic tools may be beneficial. As an example, in one trial, CPAP use at 90 days was higher in those who received telehealth education and telemonitoring web-based feedback compared with usual care (4.8 versus 3.8 hours of nightly use) [<a href="#rid61">61</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Active patient engagement (APE) – Several CPAP manufacturers have developed cloud-based technology to promote adherence through patient engagement. This technology provides feedback to the patient on a number of outcomes including hours of CPAP use, presence of a leak, residual AHI, in addition to coaching messages based on cognitive behavioral therapy (see <a class="local">'Cognitive behavioral therapy'</a> below). One study reported that patients who accessed APE manufacturer cloud-based feedback services used their CPAP one hour longer per night compared with patients who didn’t access APE services (5.9 hours/night versus 4.9 hours/night) [<a href="#rid62">62</a>]. In addition, a greater proportion of the APE group met Medicare adherence requirements (87.3 versus 70.4 percent).</p><p></p><p class="headingAnchor" id="H7"><span class="h1">FIRST-LINE INTERVENTIONS</span><span class="headingEndMark"> — </span>In patients with OSA, we believe in an integrated approach to management that involves behavioral therapy and prompt management of side effects. This approach has been shown to increase CPAP use by about one hour, sometimes more [<a href="#rid66">66</a>]. </p><p class="headingAnchor" id="H991362669"><span class="h2">Behavioral therapy</span><span class="headingEndMark"> — </span>Consistent with the American Academy of Sleep Medicine recommendation, we suggest that all patients with OSA being treated with CPAP receive behavioral therapy before and during the first few weeks of therapy [<a href="#rid47">47</a>]. Therapies include cognitive behavioral therapy (CBT) and motivational enhancement therapy (MET). Behavioral therapy can be delivered by a psychologist or advanced practice nurse. It can be performed during a telephone call or during an in-person or telehealth visit. However, it is unclear if one form is superior to another or if different behavioral interventions are best for different patient phenotypes. We encourage support from a bed partner or significant other (eg, CPAP “buddy”), especially since it has been shown that bed partner response to CPAP therapy also affects adherence [<a href="#rid56">56,57,67</a>]. Therapy is best administered before and during the first month of starting CPAP but can be offered at any time. </p><p>This recommendation is based upon data that suggest behavioral interventions that focus on intensive patient support and reinforcement of positive behaviors, improve CPAP adherence by approximately one hour per night [<a href="#rid66">66,68</a>]. In a meta-analysis that included 41 small randomized trials of CPAP-naïve patients with OSA, behavioral therapies were associated with increased CPAP adherence (mean improvement 50 minutes per night) [<a href="#rid66">66</a>]. Among the high-quality trials, behavioral therapies improved CPAP adherence by a mean of 1.3 hours per night and also increased the number of patients who used their machines for four or more hours/night (371 to 501 per 1000;odds ratio 1.70). However, flaws included significant heterogeneity across studies, the small effect size, and the lack of reporting on the effect of behavioral therapies on daytime sleepiness. </p><p class="headingAnchor" id="H1576169369"><span class="h3">Cognitive behavioral therapy</span><span class="headingEndMark"> — </span>CBT is a structured psychotherapeutic method used to alter attitudes and behaviors. The positive effect of CBT plus education on adherence with CPAP is likely due to improved self-efficacy (defined as one's motivation, volition, and confidence to engage in a healthy behavior). CBT may take many forms including videos demonstrating CPAP use, electronic or pamphlet information, relaxation techniques, mask fitting sessions, and telephone or telehealth support. CBT usually takes place over several sessions during the first two weeks and is usually delivered by a psychologist or advanced practice nurse. </p><p>The efficacy of CBT plus education has been reported in several randomized trials [<a href="#rid69">69-71</a>]. As examples</p><p class="bulletIndent1"><span class="glyph">●</span>One trial randomly assigned 96 men with OSA to either usual treatment with mask-fitting and basic information regarding CPAP (the control group) or two one-hour cognitive behavioral interventions that included a video of real CPAP users and relaxation techniques as well as mask-fitting and basic information regarding CPAP (the CBT group) [<a href="#rid69">69</a>]. After 28 days of treatment, patients in the CBT group were more likely to accept CPAP therapy compared with controls; in addition, patients who underwent CBT had greater hours of nightly use (5.38 versus 2.51 hours/night) and a greater proportion used their CPAP device for four or more hours/night (50 versus 15 percent). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another trial utilized an automated telephone-linked communication system adapted for CPAP to provide regular telephone sessions that included assessment of the participant’s experience with CPAP, self-reported machine use, feedback, and counseling [<a href="#rid70">70</a>]. After six months, the median CPAP usage was approximately one hour greater in the 124 patients randomly assigned to the telephone sessions compared with those assigned to an attention control intervention (ie, no feedback was provided). </p><p></p><p class="headingAnchor" id="H368727774"><span class="h3">Motivational enhancement</span><span class="headingEndMark"> — </span>Motivational enhancement therapy (MET) addresses the components of CPAP adherence that can be modified such as perception and behavior. Aspects of motivational interviewing include interaction with the patient in person (two to three sessions) and by phone during the first month to resolve perceptions, behaviors, and volitions that are barriers to engaging in the treatment. When delivering this therapy, we support an empathic approach that enhances the patient's self-efficacy, is not reactive to resistance, and assists the patient in the identification of specific goals for CPAP use. MET may be administered by nurses or trained psychologists during a telephone, in-person, or telehealth encounter. </p><p>Several randomized studies have demonstrated increased CPAP use with motivational interviewing but the effect may be lost once it’s stopped [<a href="#rid41">41,72</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>One randomized study of 106 adults with a new diagnosis of OSA reported that patients who received motivational interview nurse therapy (MINT) with CPAP had improved adherence at three months compared with patients who were treated with CPAP alone (4.6 versus 3.2 hours per night) [<a href="#rid41">41</a>]. However, the effect was lost at 12 months. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another randomized trial of 83 patients with moderate to severe OSA, adherence improved by 99 minutes per night in those who received eight months of MET with CPAP compared with CPAP alone [<a href="#rid72">72</a>]. The effect was persistent in those who continued to receive therapy.  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study, downloaded CPAP data was used to trigger an intervention designed to improve adherence in 113 patients with OSA and compared with 110 patients who did not receive the intervention. The intervention was two telephone calls per month based on two days with &lt;4 hours/night use or a leak greater than two days of &gt;0.5 L/second. Those who received the intervention demonstrated greater CPAP use (5.3 versus 4.6 hours/night), used their CPAP for a greater number of nights, and had a higher number of nights with four or more hours/night use [<a href="#rid65">65</a>]. </p><p></p><p class="headingAnchor" id="H8"><span class="h2">Side effect management</span><span class="headingEndMark"> — </span>We suggest early troubleshooting of side effects, initiated by the provider team within the first few days to two weeks of CPAP use. Prompt intervention should enhance comfort and self-efficacy (defined as one's motivation, volition, and confidence to engage in a healthy behavior), which have been shown to promote CPAP adherence [<a href="#rid9">9,27,28</a>]. A multidisciplinary approach to managing side effects related to CPAP therapy has been developed and is illustrated in the figure  (<a class="graphic graphic_algorithm graphicRef66488" href="/z/d/graphic/66488.html" rel="external">algorithm 1</a>) [<a href="#rid16">16</a>]. </p><p>In most cases, the assessment and troubleshooting can be done during provider follow-up with the patient at home using telehealth or in-person visits with an experienced sleep technician. (See <a class="local">'Frequent provider follow-up during first two weeks'</a> above.)</p><p class="headingAnchor" id="H3796318595"><span class="h3">Interface (mask)-related issues</span><span class="headingEndMark"> — </span>An ill-fitting mask may be responsible for discomfort on the face, pressure ulcers on the nose and cheeks, and air leaks leading to poor efficacy. Ideally, at the <strong>initiation</strong> of CPAP, time should be spent with the patient educating them regarding the importance of a good seal and optimization of the of mask fit. We believe that patients should be active participants in mask selection and identify a preference for nasal mask, nasal pillows, or full-face mask as well as the specific brand they prefer. </p><p>We advocate for an initial acclimatization period where the patient is taught how to place the mask on their face and tolerate the pressure for a short period (eg, while awake or watching TV); the patient slowly increases their time and pressure until their targeted goal is reached. </p><p>However, in some cases, patients have trouble tolerating the mask despite acclimatization or have trouble later in their treatment course due to issues such as a change in weight or dentition. Simple solutions involve giving the patient the choice of mask or interface, resizing the existing mask, changing the type of interface (eg, nasal or oronasal mask), or changing the cushioning on the interface. Retitration of CPAP may need to be performed when the interface is changed. </p><p>Selecting an appropriate interface and titration of CPAP are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7677.html" rel="external">"Titration of positive airway pressure therapy for adults with obstructive sleep apnea", section on 'Choosing the correct patient-device interface'</a>.)</p><p class="headingAnchor" id="H2514030779"><span class="h3">Intolerant of pressure</span><span class="headingEndMark"> — </span>Some patients cannot tolerate fixed-level CPAP due to the feeling of pressure from the device. In such cases, using a flexible pressure device enables the patient to set the initial pressure prior to ramping up to the prescribed pressure before switching to an auto titratable CPAP (APAP) device or to bilevel positive airway pressure (BPAP); the latter may necessitate another in-laboratory titration. (See  <a class="medical medical_review" href="/z/d/html/7677.html" rel="external">"Titration of positive airway pressure therapy for adults with obstructive sleep apnea", section on 'Intolerance of the sensation of pressure'</a>.)</p><p class="headingAnchor" id="H2718462299"><span class="h3">Nasal or upper airway dryness or congestion</span><span class="headingEndMark"> — </span>Although typically administered routinely, we employ heated humidification in cases where it can alleviate nasal dryness. For those with congestion, several topical agents (eg, antimuscarinic agents, anti-histamines, corticosteroids) or changing the facemask can be attempted. (See  <a class="medical medical_review" href="/z/d/html/7677.html" rel="external">"Titration of positive airway pressure therapy for adults with obstructive sleep apnea", section on 'Nasal congestion'</a> and  <a class="medical medical_review" href="/z/d/html/7677.html" rel="external">"Titration of positive airway pressure therapy for adults with obstructive sleep apnea", section on 'Nasal dryness (heated humidification)'</a>.)</p><p class="headingAnchor" id="H3315741113"><span class="h3">Oral air leaks</span><span class="headingEndMark"> — </span>For patients with air leaks via the mouth, we typically add a chin strap or switch to an oronasal mask and then examine downloaded data during a future visit to ensure a reduction in leak and improvement in apnea-hypopnea (AHI<sub>flow</sub>) with these maneuvers [<a href="#rid73">73</a>]. (See  <a class="medical medical_review" href="/z/d/html/7677.html" rel="external">"Titration of positive airway pressure therapy for adults with obstructive sleep apnea", section on 'Mouth breathing and air leaks'</a>.) </p><p class="headingAnchor" id="H1047419350"><span class="h3">Others</span><span class="headingEndMark"> — </span>Identification and management of other issues that may interfere with adherence include the following (see  <a class="medical medical_review" href="/z/d/html/7677.html" rel="external">"Titration of positive airway pressure therapy for adults with obstructive sleep apnea", section on 'Others'</a>): </p><p class="bulletIndent1"><span class="glyph">●</span>Education for issues surrounding intimacy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Switching to a nasal mask or pillows for aerophagia</p><p></p><p class="headingAnchor" id="H1802270715"><span class="h1">PATIENTS WHO FAIL FIRST-LINE INTERVENTIONS</span><span class="headingEndMark"> — </span>Measures discussed in this topic should improve patient adherence. However, an analysis of 82 articles examining interventions for adherence reported that the overall CPAP nonadherence rate based on a seven hours/night sleep time was stable over the 20 year period at 34 percent [<a href="#rid68">68</a>], indicating the individualized nature of the response. Future research should center on identifying who best responds from which intervention reflecting person-centered health care. In general, for those who fail first-line interventions, we persist with education and behavioral therapy. Pharmacologic therapy in the form of a sedative-hypnotic sleep aid is a last resort but may be attempted on a trial basis. </p><p class="headingAnchor" id="H10"><span class="h2">Pharmacological therapy</span><span class="headingEndMark"> — </span>We do not suggest routine use of a sedative-hypnotic at the time of CPAP initiation. This recommendation is based on the greater risk of side effects and conflicting data regarding such therapy. However, a short-term trial of sedative hypnotic therapy may be tried in those who fail all other options (eg, one to two weeks).</p><p>Randomized studies have yielded conflicting results:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Single-dose therapy</strong> – One trial randomly assigned 117 patients with OSA (mean apnea hypopnea index [AHI] 29 events per hour) to receive premedication with a single dose of <a class="drug drug_general" data-topicid="8830" href="/z/d/drug information/8830.html" rel="external">eszopiclone</a> (3 mg) or placebo 30 minutes prior to attended polysomnography (PSG) for CPAP titration [<a href="#rid74">74</a>]. Four to six weeks later, the eszopiclone group used their CPAP on more nights (76 versus 60 percent of nights) and for a longer duration (four versus three hours) than the placebo group. However, loss of follow-up was significant among both groups.</p><p></p><p class="bulletIndent1">In contrast, in a second study of 134 patients with OSA (median AHI 17 events per hour) undergoing initial split-night PSG, there was no difference in the median daily CPAP use at one month among those who were randomly assigned to receive a single dose of <a class="drug drug_general" data-topicid="10334" href="/z/d/drug information/10334.html" rel="external">zaleplon</a> or placebo (6.5 hours each) [<a href="#rid75">75</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Two weeks course of therapy</strong> – Extended dosing was tested in a trial that randomized 72 male CPAP-naïve patients with OSA (mean AHI 42 events per hour) to <a class="drug drug_general" data-topicid="10057" href="/z/d/drug information/10057.html" rel="external">zolpidem</a>, placebo, or standard of care for the first 14 days of CPAP therapy [<a href="#rid76">76</a>]. After one month, there was no difference in CPAP adherence among the three groups as measured by average nightly CPAP use (approximately four to five hours) or total days used.</p><p></p><p class="bulletIndent1">In contrast, in a subsequent trial, 160 patients with newly diagnosed OSA (mean AHI 37 events per hour) were randomly assigned to receive <a class="drug drug_general" data-topicid="8830" href="/z/d/drug information/8830.html" rel="external">eszopiclone</a> (3 mg) or placebo during the initial 14 nights of CPAP therapy [<a href="#rid77">77</a>]. After six months of follow-up, patients who received eszopiclone used their CPAP device for more nights (64 versus 45 percent of nights) and for a longer duration (four versus three hours), and were less likely to discontinue CPAP therapy (42 versus 58 percent) than the patients taking placebo. </p><p></p><p>One meta-analysis of eight studies that included over 1000 patients with OSA reported that patients who were treated with nonbenzodiazepine sedative hypnotics had higher rates of adherence than those who did not receive such medication (six studies were placebo controlled) [<a href="#rid78">78</a>]. Patients treated with nonbenzodiazepine sedative hypnotics tolerated CPAP by 0.62 hours more per night and had a 12 percent increase in the number of nights used. After removing one study with significant heterogeneity, patients receiving nonbenzodiazepine sedative hypnotics were more than twice as likely to have good adherence using the definition described above (see <a class="local">'Definition (hours of CPAP use)'</a> above). The results of this analysis were heavily influenced by trials that used <a class="drug drug_general" data-topicid="8830" href="/z/d/drug information/8830.html" rel="external">eszopiclone</a>, and larger randomized trials are needed before making firm conclusions regarding the use of sedatives to encourage CPAP adherence.</p><p class="headingAnchor" id="H386692646"><span class="h2">Other options</span><span class="headingEndMark"> — </span>If the side effects persist despite adequate intervention, we typically repeat a titration study with fixed-level CPAP or have patients undergo a trial of auto-titrating CPAP (APAP) or bilevel positive airway pressure (BPAP) [<a href="#rid79">79</a>]. Alternatively, other treatments for OSA such as oral appliance, surgery, or hypoglossal nerve stimulation should be considered. (See  <a class="medical medical_review" href="/z/d/html/7678.html" rel="external">"Oral appliances in the treatment of obstructive sleep apnea in adults"</a> and  <a class="medical medical_review" href="/z/d/html/97861.html" rel="external">"Surgical treatment of obstructive sleep apnea in adults"</a>.)</p><p class="headingAnchor" id="H3597265132"><span class="h1">PATIENTS WHO ARE ADHERENT WITH RESIDUAL SLEEPINESS</span><span class="headingEndMark"> — </span>For patients who are adherent <strong>and</strong> in whom CPAP is adequate but who remain sleepy, we evaluate for other etiologies of excessive sleepiness and suitability for a wakefulness-promoting agent. (See  <a class="medical medical_review" href="/z/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness"</a> and  <a class="medical medical_review" href="/z/d/html/7687.html" rel="external">"Evaluation and management of residual excessive sleepiness in adults with obstructive sleep apnea"</a>.)</p><p class="headingAnchor" id="H3352670380"><span class="h1">USEFUL RESOURCES</span><span class="headingEndMark"> — </span>Educational materials such as pamphlets and videotapes for both clinicians and patients are available from several sites including <a class="external" href="/external-redirect?target_url=https%3A%2F%2Faasm.org%2F&amp;token=Wq%2B4%2B5azEhok37uAZduxeZR2UEeg5iuJS4ZlgjZusZg%3D&amp;TOPIC_ID=7702" target="_blank">The American Academy of Sleep Medicine</a>, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.sleepfoundation.org%2F&amp;token=FWNID0ZRoEvvwjKjY4KwHTbd6s9qjobLqKIfWwGJ%2B2eKa8W0Tl%2B9K3ywYpz%2FQZF%2F&amp;TOPIC_ID=7702" target="_blank">The Sleep Foundation</a>, and <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.sleepapnea.org%2F&amp;token=FWNID0ZRoEvvwjKjY4KwHU6f9%2F9%2FZA086WpZAIGuVs3nC9cTmVnhVlRAMDuymZTq&amp;TOPIC_ID=7702" target="_blank">The American Sleep Apnea Association</a>. </p><p class="headingAnchor" id="H3735953378"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113310.html" rel="external">"Society guideline links: Sleep-related breathing disorders in adults"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Continuous positive airway pressure (CPAP) is an effective therapy for obstructive sleep apnea (OSA), but adherence is suboptimal in over half of patients. (See <a class="local">'Nonadherence'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We suggest that a cutoff of less than four hours and/or less than 70 percent of nights (ie, five out of seven nights) be used as a general metric to define nonadherence. However, outcome expectations should be individually defined to determine the appropriate target for nightly usage. (See <a class="local">'Definition (hours of CPAP use)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The benefits of CPAP therapy are generally felt within a few weeks of CPAP therapy (eg, improved daytime sleepiness, systemic blood pressure, quality of life, neurobehavioral performance, and a reduced risk of motor vehicle accidents). (See <a class="local">'Sequalae'</a> above and  <a class="medical medical_review" href="/z/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults", section on 'Efficacy'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Risk factors for nonadherence should be explored and are shown in the table  (<a class="graphic graphic_table graphicRef50144" href="/z/d/graphic/50144.html" rel="external">table 1</a>). (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – We advocate a multidisciplinary approach to the evaluation and management of adherence. Effective teams consist of experienced personnel (eg, physician, technologist, advanced practice nurse, psychologist), and the bed partner. Follow-up consists of in-person or telehealth encounters and telephone contact. (See <a class="local">'Evaluation for nonadherence'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Frequent contact and follow-up with a health care provider who has expertise in treating sleep disorders is especially important during the <strong>first two weeks</strong> of therapy. (See <a class="local">'Frequent provider follow-up during first two weeks'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients and their bed partner should be asked directly about their estimated hours of nightly use, frequency of weekly use, presence of side effects explaining nonadherence, their perception of CPAP efficacy, the impact of CPAP on their bed partner, and any psychosocial issues that may be impeding therapy. In addition, data should be downloaded from the patients CPAP device that provides information about adherence, mask leaks, and an estimated apnea hypopnea index (AHI<sub>flow</sub>). (See <a class="local">'Clinical assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Interventions to prevent and treat nonadherence</strong> – First-line interventions that promote adherence in all patients with OSA who receive CPAP include behavioral therapy and aggressive side effect management (see <a class="local">'First-line interventions'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Behavioral therapy</strong> - For patients with OSA who are prescribed CPAP, we suggest behavioral therapy rather than no behavioral therapy (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). This recommendation is based upon evidence from randomized trials that suggest benefit in terms of hours used per night and proportion of patients using CPAP. Therapies include cognitive behavioral therapy (CBT) and motivational enhancement therapy (MET). Therapy is best administered before and during the first month of starting CPAP but can be offered at any time. (See <a class="local">'Behavioral therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Side effect management</strong> – Simultaneous with behavioral therapy, we also advocate early and aggressive CPAP side effect management (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>) as illustrated in the figure  (<a class="graphic graphic_algorithm graphicRef66488" href="/z/d/graphic/66488.html" rel="external">algorithm 1</a>). This approach recognizes that most side effects can be corrected by simple interventions. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pharmacologic therapy</strong> – For patients with OSA who are initiated on CPAP and are nonadherent, we suggest <strong>not </strong>routinely using of a sedative-hypnotic to encourage adherence (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). This recommendation is based upon the risk of adverse effects and conflicting data regarding the benefits of such therapy. However, in patients with OSA on CPAP who are refractory to first-line interventions of behavioral therapy and side effect management, a short trial of a sedative-hypnotic is reasonable (no greater than two weeks). (See <a class="local">'Pharmacological therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other</strong> – Failing these measures, a repeat titration study with, for example, fixed-level CPAP, auto-titrating CPAP, or bilevel positive airway pressure (BPAP) is appropriate. Alternatively, therapies such as oral appliance devices or surgery may also be considered. (See <a class="local">'Patients who fail first-line interventions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients who are adherent <strong>and</strong> in whom CPAP is adequate but who remain sleepy, we evaluate for other etiologies of excessive sleepiness and suitability for a wakefulness-promoting agent. (See  <a class="medical medical_review" href="/z/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness"</a> and  <a class="medical medical_review" href="/z/d/html/7687.html" rel="external">"Evaluation and management of residual excessive sleepiness in adults with obstructive sleep apnea"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sawyer AM, Gooneratne NS, Marcus CL, et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 2011; 15:343.</a></li><li><a class="nounderline abstract_t">Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007; 30:711.</a></li><li><a class="nounderline abstract_t">Zimmerman ME, Arnedt JT, Stanchina M, et al. Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea. Chest 2006; 130:1772.</a></li><li><a class="nounderline abstract_t">Antic NA, Catcheside P, Buchan C, et al. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 2011; 34:111.</a></li><li><a class="nounderline abstract_t">Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 2012; 307:2161.</a></li><li><a class="nounderline abstract_t">Bratton DJ, Stradling JR, Barbé F, Kohler M. Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials. Thorax 2014; 69:1128.</a></li><li><a class="nounderline abstract_t">Craig SE, Kohler M, Nicoll D, et al. Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial. Thorax 2012; 67:1090.</a></li><li><a class="nounderline abstract_t">Stradling JR, Davies RJ. Is more NCPAP better? Sleep 2000; 23 Suppl 4:S150.</a></li><li><a class="nounderline abstract_t">Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008; 5:173.</a></li><li><a class="nounderline abstract_t">Gay P, Weaver T, Loube D, et al. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 2006; 29:381.</a></li><li><a class="nounderline abstract_t">Gervès-Pinquié C, Bailly S, Goupil F, et al. Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep Apnea. Am J Respir Crit Care Med 2022; 206:1393.</a></li><li><a class="nounderline abstract_t">Kribbs NB, Pack AI, Kline LR, et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147:1162.</a></li><li><a class="nounderline abstract_t">Grunstein RR, Stewart DA, Lloyd H, et al. Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones. Sleep 1996; 19:774.</a></li><li><a class="nounderline abstract_t">Young LR, Taxin ZH, Norman RG, et al. Response to CPAP withdrawal in patients with mild versus severe obstructive sleep apnea/hypopnea syndrome. Sleep 2013; 36:405.</a></li><li><a class="nounderline abstract_t">Kohler M, Stoewhas AC, Ayers L, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2011; 184:1192.</a></li><li><a class="nounderline abstract_t">Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev 2003; 7:81.</a></li><li><a class="nounderline abstract_t">Weaver TE. Adherence to positive airway pressure therapy. Curr Opin Pulm Med 2006; 12:409.</a></li><li><a class="nounderline abstract_t">Ye L, Pack AI, Maislin G, et al. Predictors of continuous positive airway pressure use during the first week of treatment. J Sleep Res 2012; 21:419.</a></li><li><a class="nounderline abstract_t">May AM, Gharibeh T, Wang L, et al. CPAP Adherence Predictors in a Randomized Trial of Moderate-to-Severe OSA Enriched With Women and Minorities. Chest 2018; 154:567.</a></li><li><a class="nounderline abstract_t">Villa Alvarez J, Dales R, Kendzerska T. Demographics, sleep apnea and positive airway pressure (PAP) treatment-related characteristics associated with PAP adherence: A large retrospective community-based longitudinal observational study. Sleep Med 2022; 98:139.</a></li><li><a class="nounderline abstract_t">Younes MK, Beaudin AE, Raneri JK, et al. Adherence Index: sleep depth and nocturnal hypoventilation predict long-term adherence with positive airway pressure therapy in severe obstructive sleep apnea. J Clin Sleep Med 2022; 18:1933.</a></li><li><a class="nounderline abstract_t">Pengo MF, Czaban M, Berry MP, et al. The effect of positive and negative message framing on short term continuous positive airway pressure compliance in patients with obstructive sleep apnea. J Thorac Dis 2018; 10:S160.</a></li><li><a class="nounderline abstract_t">Hsu N, Zeidler MR, Ryden AM, Fung CH. Racial disparities in positive airway pressure therapy adherence among veterans with obstructive sleep apnea. J Clin Sleep Med 2020; 16:1249.</a></li><li><a class="nounderline abstract_t">Rosenthal L, Gerhardstein R, Lumley A, et al. CPAP therapy in patients with mild OSA: implementation and treatment outcome. Sleep Med 2000; 1:215.</a></li><li><a class="nounderline abstract_t">Lewis KE, Seale L, Bartle IE, et al. Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep 2004; 27:134.</a></li><li><a class="nounderline abstract_t">Shapiro GK, Shapiro CM. Factors that influence CPAP adherence: an overview. Sleep Breath 2010; 14:323.</a></li><li><a class="nounderline abstract_t">Stepnowsky CJ Jr, Marler MR, Ancoli-Israel S. Determinants of nasal CPAP compliance. Sleep Med 2002; 3:239.</a></li><li><a class="nounderline abstract_t">Aloia MS, Arnedt JT, Stepnowsky C, et al. Predicting treatment adherence in obstructive sleep apnea using principles of behavior change. J Clin Sleep Med 2005; 1:346.</a></li><li><a class="nounderline abstract_t">Dzierzewski JM, Wallace DM, Wohlgemuth WK. Adherence to Continuous Positive Airway Pressure in Existing Users: Self-Efficacy Enhances the Association between Continuous Positive Airway Pressure and Adherence. J Clin Sleep Med 2016; 12:169.</a></li><li><a class="nounderline abstract_t">Chasens ER, Pack AI, Maislin G, et al. Claustrophobia and adherence to CPAP treatment. West J Nurs Res 2005; 27:307.</a></li><li><a class="nounderline abstract_t">Stepnowsky CJ Jr, Bardwell WA, Moore PJ, et al. Psychologic correlates of compliance with continuous positive airway pressure. Sleep 2002; 25:758.</a></li><li><a class="nounderline abstract_t">Kohler M, Smith D, Tippett V, Stradling JR. Predictors of long-term compliance with continuous positive airway pressure. Thorax 2010; 65:829.</a></li><li><a class="nounderline abstract_t">Drake CL, Day R, Hudgel D, et al. Sleep during titration predicts continuous positive airway pressure compliance. Sleep 2003; 26:308.</a></li><li><a class="nounderline abstract_t">Sugiura T, Noda A, Nakata S, et al. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome. Respiration 2007; 74:56.</a></li><li><a class="nounderline abstract_t">Li HY, Engleman H, Hsu CY, et al. Acoustic reflection for nasal airway measurement in patients with obstructive sleep apnea-hypopnea syndrome. Sleep 2005; 28:1554.</a></li><li><a class="nounderline abstract_t">Morris LG, Burschtin O, Lebowitz RA, et al. Nasal obstruction and sleep-disordered breathing: a study using acoustic rhinometry. Am J Rhinol 2005; 19:33.</a></li><li><a class="nounderline abstract_t">Bengtsson C, Grote L, Ljunggren M, et al. Nasal polyposis is a risk factor for nonadherence to CPAP treatment in sleep apnea: the population-based DISCOVERY study. J Clin Sleep Med 2023; 19:573.</a></li><li><a class="nounderline abstract_t">Wallace DM, Sawyer AM, Shafazand S. Comorbid insomnia symptoms predict lower 6-month adherence to CPAP in US veterans with obstructive sleep apnea. Sleep Breath 2018; 22:5.</a></li><li><a class="nounderline abstract_t">Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999; 116:403.</a></li><li><a class="nounderline abstract_t">Neill AM, Wai HS, Bannan SP, et al. Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. Eur Respir J 2003; 22:258.</a></li><li><a class="nounderline abstract_t">Olsen S, Smith SS, Oei TP, Douglas J. Motivational interviewing (MINT) improves continuous positive airway pressure (CPAP) acceptance and adherence: a randomized controlled trial. J Consult Clin Psychol 2012; 80:151.</a></li><li><a class="nounderline abstract_t">Kreivi HR, Maasilta P, Bachour A. Persistence of Upper-Airway Symptoms During CPAP Compromises Adherence at 1 Year. Respir Care 2016; 61:652.</a></li><li><a class="nounderline abstract_t">Palm A, Midgren B, Theorell-Haglöw J, et al. Factors influencing adherence to continuous positive airway pressure treatment in obstructive sleep apnea and mortality associated with treatment failure - a national registry-based cohort study. Sleep Med 2018; 51:85.</a></li><li><a class="nounderline abstract_t">Mador MJ, Krauza M, Pervez A, et al. Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest 2005; 128:2151.</a></li><li><a class="nounderline abstract_t">Worsnop CJ, Miseski S, Rochford PD. Routine use of humidification with nasal continuous positive airway pressure. Intern Med J 2010; 40:650.</a></li><li><a class="nounderline abstract_t">Ryan S, Doherty LS, Nolan GM, McNicholas WT. Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure. J Clin Sleep Med 2009; 5:422.</a></li><li><a class="nounderline abstract_t">Patil SP, Ayappa IA, Caples SM, et al. Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2019; 15:335.</a></li><li><a class="nounderline abstract_t">Ayas NT, Patel SR, Malhotra A, et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep 2004; 27:249.</a></li><li><a class="nounderline abstract_t">Nilius G, Happel A, Domanski U, Ruhle KH. Pressure-relief continuous positive airway pressure vs constant continuous positive airway pressure: a comparison of efficacy and compliance. Chest 2006; 130:1018.</a></li><li><a class="nounderline abstract_t">Stanchina M, Lincoln J, Prenda S, et al. The impact of different CPAP delivery approaches on nightly adherence and discontinuation rate in patients with obstructive sleep apnea. J Clin Sleep Med 2022; 18:2023.</a></li><li><a class="nounderline abstract_t">Patel SR, Bakker JP, Stitt CJ, et al. Impact of an Extended Telemonitoring and Coaching Program on Continuous Positive Airway Pressure Adherence. Ann Am Thorac Soc 2022; 19:2070.</a></li><li><a class="nounderline abstract_t">Fridriksson B, Berndtson M, Hamnered H, et al. Beneficial Effects of Early Intervention Telemedicine-based Follow-Up in Sleep Apnea: A Randomized Controlled Multicenter Trial. Ann Am Thorac Soc 2023; 20:1499.</a></li><li><a class="nounderline abstract_t">Aloia MS, Arnedt JT, Stanchina M, Millman RP. How early in treatment is PAP adherence established? Revisiting night-to-night variability. Behav Sleep Med 2007; 5:229.</a></li><li><a class="nounderline abstract_t">Budhiraja R, Parthasarathy S, Drake CL, et al. Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep 2007; 30:320.</a></li><li><a class="nounderline abstract_t">Sucena M, Liistro G, Aubert G, et al. Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users. Eur Respir J 2006; 27:761.</a></li><li><a class="nounderline abstract_t">Ye L, Antonelli MT, Willis DG, et al. Couples' experiences with continuous positive airway pressure treatment: a dyadic perspective. Sleep Health 2017; 3:362.</a></li><li><a class="nounderline abstract_t">Gentina T, Bailly S, Jounieaux F, et al. Marital quality, partner's engagement and continuous positive airway pressure adherence in obstructive sleep apnea. Sleep Med 2019; 55:56.</a></li><li><a class="nounderline abstract_t">Schwab RJ, Badr SM, Epstein LJ, et al. An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems. The optimal monitoring strategies and outcome measures in adults. Am J Respir Crit Care Med 2013; 188:613.</a></li><li><a class="nounderline abstract_t">Munafo D, Hevener W, Crocker M, et al. A telehealth program for CPAP adherence reduces labor and yields similar adherence and efficacy when compared to standard of care. Sleep Breath 2016; 20:777.</a></li><li><a class="nounderline abstract_t">Turino C, de Batlle J, Woehrle H, et al. Management of continuous positive airway pressure treatment compliance using telemonitoring in obstructive sleep apnoea. Eur Respir J 2017; 49.</a></li><li><a class="nounderline abstract_t">Hwang D, Chang JW, Benjafield AV, et al. Effect of Telemedicine Education and Telemonitoring on Continuous Positive Airway Pressure Adherence. The Tele-OSA Randomized Trial. Am J Respir Crit Care Med 2018; 197:117.</a></li><li><a class="nounderline abstract_t">Malhotra A, Crocker ME, Willes L, et al. Patient Engagement Using New Technology to Improve Adherence to Positive Airway Pressure Therapy: A Retrospective Analysis. Chest 2018; 153:843.</a></li><li><a class="nounderline abstract_t">Shaughnessy GF, Morgenthaler TI. The Effect of Patient-Facing Applications on Positive Airway Pressure Therapy Adherence: A Systematic Review. J Clin Sleep Med 2019; 15:769.</a></li><li><a class="nounderline abstract_t">Fox N, Hirsch-Allen AJ, Goodfellow E, et al. The impact of a telemedicine monitoring system on positive airway pressure adherence in patients with obstructive sleep apnea: a randomized controlled trial. Sleep 2012; 35:477.</a></li><li><a class="nounderline abstract_t">Frasnelli M, Baty F, Niedermann J, et al. Effect of telemetric monitoring in the first 30 days of continuous positive airway pressure adaptation for obstructive sleep apnoea syndrome - a controlled pilot study. J Telemed Telecare 2016; 22:209.</a></li><li><a class="nounderline abstract_t">Askland K, Wright L, Wozniak DR, et al. Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev 2020; 4:CD007736.</a></li><li><a class="nounderline abstract_t">Parthasarathy S, Wendel C, Haynes PL, et al. A pilot study of CPAP adherence promotion by peer buddies with sleep apnea. J Clin Sleep Med 2013; 9:543.</a></li><li><a class="nounderline abstract_t">Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg 2016; 45:43.</a></li><li><a class="nounderline abstract_t">Richards D, Bartlett DJ, Wong K, et al. Increased adherence to CPAP with a group cognitive behavioral treatment intervention: a randomized trial. Sleep 2007; 30:635.</a></li><li><a class="nounderline abstract_t">Sparrow D, Aloia M, Demolles DA, Gottlieb DJ. A telemedicine intervention to improve adherence to continuous positive airway pressure: a randomised controlled trial. Thorax 2010; 65:1061.</a></li><li><a class="nounderline abstract_t">Sweetman A, Lack L, Catcheside PG, et al. Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial. Sleep 2019; 42.</a></li><li><a class="nounderline abstract_t">Bakker JP, Wang R, Weng J, et al. Motivational Enhancement for Increasing Adherence to CPAP: A Randomized Controlled Trial. Chest 2016; 150:337.</a></li><li><a class="nounderline abstract_t">Knowles SR, O'Brien DT, Zhang S, et al. Effect of addition of chin strap on PAP compliance, nightly duration of use, and other factors. J Clin Sleep Med 2014; 10:377.</a></li><li><a class="nounderline abstract_t">Lettieri CJ, Collen JF, Eliasson AH, Quast TM. Sedative use during continuous positive airway pressure titration improves subsequent compliance: a randomized, double-blind, placebo-controlled trial. Chest 2009; 136:1263.</a></li><li><a class="nounderline abstract_t">Park JG, Olson EJ, Morgenthaler TI. Impact of zaleplon on continuous positive airway pressure therapy compliance. J Clin Sleep Med 2013; 9:439.</a></li><li><a class="nounderline abstract_t">Bradshaw DA, Ruff GA, Murphy DP. An oral hypnotic medication does not improve continuous positive airway pressure compliance in men with obstructive sleep apnea. Chest 2006; 130:1369.</a></li><li><a class="nounderline abstract_t">Lettieri CJ, Shah AA, Holley AB, et al. Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial. Ann Intern Med 2009; 151:696.</a></li><li><a class="nounderline abstract_t">Wang D, Tang Y, Chen Y, et al. The effect of non-benzodiazepine sedative hypnotics on CPAP adherence in patients with OSA: a systematic review and meta-analysis. Sleep 2021; 44.</a></li><li><a class="nounderline abstract_t">Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009; 5:263.</a></li></ol></div><div id="topicVersionRevision">Topic 7702 Version 49.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21652236" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17580592" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17166995" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21203366" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22618923" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24947425" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23111478" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10893091" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Is more NCPAP better?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18250209" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Adherence to continuous positive airway pressure therapy: the challenge to effective treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16553025" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35816570" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep Apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8484626" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9085485" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Acute withdrawal of nasal CPAP in obstructive sleep apnea does not cause a rise in stress hormones.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23449493" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Response to CPAP withdrawal in patients with mild versus severe obstructive sleep apnea/hypopnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21836134" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12586532" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17053489" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Adherence to positive airway pressure therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21988137" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Predictors of continuous positive airway pressure use during the first week of treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29684316" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : CPAP Adherence Predictors in a Randomized Trial of Moderate-to-Severe OSA Enriched With Women and Minorities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35839686" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Demographics, sleep apnea and positive airway pressure (PAP) treatment-related characteristics associated with PAP adherence: A large retrospective community-based longitudinal observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35499136" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Adherence Index: sleep depth and nocturnal hypoventilation predict long-term adherence with positive airway pressure therapy in severe obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29445540" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The effect of positive and negative message framing on short term continuous positive airway pressure compliance in patients with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32267221" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Racial disparities in positive airway pressure therapy adherence among veterans with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10828432" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : CPAP therapy in patients with mild OSA: implementation and treatment outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14998250" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Early predictors of CPAP use for the treatment of obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20661654" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Factors that influence CPAP adherence: an overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14592213" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Determinants of nasal CPAP compliance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17564399" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Predicting treatment adherence in obstructive sleep apnea using principles of behavior change.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26350607" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Adherence to Continuous Positive Airway Pressure in Existing Users: Self-Efficacy Enhances the Association between Continuous Positive Airway Pressure and Adherence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15781905" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Claustrophobia and adherence to CPAP treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12405612" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Psychologic correlates of compliance with continuous positive airway pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20805182" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Predictors of long-term compliance with continuous positive airway pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12749550" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Sleep during titration predicts continuous positive airway pressure compliance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16299414" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16408415" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Acoustic reflection for nasal airway measurement in patients with obstructive sleep apnea-hypopnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15794072" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Nasal obstruction and sleep-disordered breathing: a study using acoustic rhinometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36546358" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Nasal polyposis is a risk factor for nonadherence to CPAP treatment in sleep apnea: the population-based DISCOVERY study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29330768" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Comorbid insomnia symptoms predict lower 6-month adherence to CPAP in US veterans with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10453869" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12952257" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Humidified nasal continuous positive airway pressure in obstructive sleep apnoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22103957" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Motivational interviewing (MINT) improves continuous positive airway pressure (CPAP) acceptance and adherence: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26732141" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Persistence of Upper-Airway Symptoms During CPAP Compromises Adherence at 1 Year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30103074" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Factors influencing adherence to continuous positive airway pressure treatment in obstructive sleep apnea and mortality associated with treatment failure - a national registry-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16236868" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19460056" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Routine use of humidification with nasal continuous positive airway pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19961025" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30736887" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15124718" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17035433" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Pressure-relief continuous positive airway pressure vs constant continuous positive airway pressure: a comparison of efficacy and compliance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35499279" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The impact of different CPAP delivery approaches on nightly adherence and discontinuation rate in patients with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35858100" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Impact of an Extended Telemonitoring and Coaching Program on Continuous Positive Airway Pressure Adherence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37463309" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Beneficial Effects of Early Intervention Telemedicine-based Follow-Up in Sleep Apnea: A Randomized Controlled Multicenter Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17680733" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : How early in treatment is PAP adherence established? Revisiting night-to-night variability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17425228" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Early CPAP use identifies subsequent adherence to CPAP therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16585083" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28923193" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Couples' experiences with continuous positive airway pressure treatment: a dyadic perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30771736" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Marital quality, partner's engagement and continuous positive airway pressure adherence in obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23992588" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : An official American Thoracic Society statement: continuous positive airway pressure adherence tracking systems. The optimal monitoring strategies and outcome measures in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26754933" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A telehealth program for CPAP adherence reduces labor and yields similar adherence and efficacy when compared to standard of care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28179438" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Management of continuous positive airway pressure treatment compliance using telemonitoring in obstructive sleep apnoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28858567" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Effect of Telemedicine Education and Telemonitoring on Continuous Positive Airway Pressure Adherence. The Tele-OSA Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29154970" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Patient Engagement Using New Technology to Improve Adherence to Positive Airway Pressure Therapy: A Retrospective Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31053207" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The Effect of Patient-Facing Applications on Positive Airway Pressure Therapy Adherence: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22467985" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The impact of a telemedicine monitoring system on positive airway pressure adherence in patients with obstructive sleep apnea: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26253747" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Effect of telemetric monitoring in the first 30 days of continuous positive airway pressure adaptation for obstructive sleep apnoea syndrome - a controlled pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32255210" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23772186" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : A pilot study of CPAP adherence promotion by peer buddies with sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27542595" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Trends in CPAP adherence over twenty years of data collection: a flattened curve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17552379" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Increased adherence to CPAP with a group cognitive behavioral treatment intervention: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20880872" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : A telemedicine intervention to improve adherence to continuous positive airway pressure: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31403168" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with comorbid insomnia: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27018174" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Motivational Enhancement for Increasing Adherence to CPAP: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24733982" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Effect of addition of chin strap on PAP compliance, nightly duration of use, and other factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19567493" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Sedative use during continuous positive airway pressure titration improves subsequent compliance: a randomized, double-blind, placebo-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23674934" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Impact of zaleplon on continuous positive airway pressure therapy compliance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17099012" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : An oral hypnotic medication does not improve continuous positive airway pressure compliance in men with obstructive sleep apnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19920270" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33769549" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The effect of non-benzodiazepine sedative hypnotics on CPAP adherence in patients with OSA: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19960649" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
